Business
REG - Novacyt S.A. - Result of AGM
REG - Novacyt S.A. - Result of AGM
About this update from Novacyt Sas
RNS Number : 4706K Novacyt S.A. 30 June 2026 Novacyt S.A.("Novacyt", the "Company" or the "Group")Result of AGMParis, France, and Manchester, UK - 30 June 2026 - Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces the results of voting on the resolutions at its Annual General Meeting ('AGM'), held today, as set out in the Notice of AGM.All Ordinary Resolutions presented at the Ordinary General Meeting were passed and Resolutions 11, 12, 15, 16, 21, 23, 24 and 25 were passed from the Extraordinary General Meeting. Full details of the results of the AGM voting are available on the Company's website.An investor presentation by Lyn Rees, Chief Executive Officer, and Steve Gibson, Chief Financial Officer, is now available on the Company's website and via the Investor Meet Company platform, with automated French subtitling https://novacyt.com/investors/presentations/Lyn Rees, CEO of Novacyt, said: "We would like to thank our shareholders for their continued support and for the approval of our key financial resolutions allowing the Group to be agile should inorganic opportunities present themselves and accelerate the process to achieve EBITDA profitability. Our focus remains on streamlining our operations and reducing our cost base enabling us to achieve sustainable long-term growth for our shareholders."ContactsNovacyt SAhttps://novacyt.com/investorsLyn Rees, Chief Executive OfficerVia Walbrook PRSteve Gibson, Chief Financial OfficerSP Angel Corporate Finance LLP (Nominated Adviser and Broker)+44 (0)20 3470 0470Matthew Johnson / Charlie Bouverat (Corporate Finance)Vadim Alexandre / Rob Rees (Corporate Broking)Singer Capital Markets (Joint Broker)+44 (0) 20 7496 3000Phil Davies / James Fischer / Samed EthemiAllegra Finance (French Listing Sponsor)Rémi Durgetto / Yannick Petit+33 (1) 42 22 10 [email protected] / [email protected] PR (Financial PR & IR)Paul McManus / Lianne ApplegarthAlice Woodings+44 (0)20 7933 8780 or [email protected]+44 (0)7980 541 893 / +44 (0)7584 391 303+44 (0)7407 804 654About Novacyt Group (www.novacyt.com)Novacyt is an international molecular diagnostics company providing a broad portfolio of integrated technologies and services, primarily focused on the delivery of genomic medicine. T...